[Regularities and paradoxes of endocrine dependence and hormonal therapy of endometrial cancer].
Bokhman
Ia V
IaV
Volkova
A T
AT
Chepik
O F
OF
Vishnevskiĭ
A S
AS
D000077713:17 alpha-Hydroxyprogesterone Caproate; D000230:Adenocarcinoma / Q000188:drug therapy / Q000503:physiopathology; D000328:Adult; D003692:Delayed-Action Preparations; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use*; D008875:Middle Aged; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy / Q000503:physiopathology; D045167:Progesterone Congeners / Q000627:therapeutic use*; D013629:Tamoxifen / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000503:physiopathology
D003692:Delayed-Action Preparations; D004965:Estrogen Antagonists; D006908:Hydroxyprogesterones; D045167:Progesterone Congeners; D013629:Tamoxifen; D000077713:17 alpha-Hydroxyprogesterone Caproate
Zakonomernosti i paradoksy éndokrinnoĭ zavisimosti i gormonoterapii raka éndometriia.